Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
2
×
national top stories
pfizer
2
×
san diego blog main
san diego top stories
san francisco blog main
acute myeloid leukemia
adverum biotechnologies
akcea therapeutics
alnylam pharmaceuticals
ambit biosciences
andrew fire
athena countouriotis
biotech
boston
boston blog main
boston top stories
brett zbar
bristol-myers squibb
clinical trials
cormorant asset management
craig mello
daiichi sankyo
fda
halozyme therapeutics
hbm healthcare investments
hbm partners
hereditary transthyretin amyloidosis
inotersen
jean cui
john maraganore
lilly asia ventures
new york blog main
new york top stories
nextech invest
nobel prize
onpattro
orbimed advisors
patisiran
What
drug
gets
2
×
afternoon
alnylam
alnylam’s
approved
athena
biotech
cancer
ceo
chief
countouriotis
fda
financing
history
landmark
making
medical
medicine
mezzanine
million
names
new
officer
ok
old
onpattro
patisiran
pharmaceuticals
promoted
push
raised
rnai
round
specifically
therapeutics
tp
year
Language
Current search:
gets
×
" national blog main "
×
pfizer
×
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
